NCT05649618 2022-12-14
TIL Cells for the Treatment of the Advanced Solid Tumors Patients
Fujian Cancer Hospital
Phase EARLY_PHASE1 Unknown
Clinical Trials
9 trialsNCT05648994 2022-12-13
TCR-T Cells for the Treatment NY-ESO-1-positive Advanced Solid Tumors
Fujian Cancer Hospital
Phase EARLY_PHASE1 Unknown
NCT05380986 2022-05-19
Camrelizumab Combined With Apatinib Mesylate
Henan Cancer Hospital
Phase NA Unknown
NCT04832204 2021-04-05
Apatinib Combined With SHR-1210 as Second-line Treatment in Solid Tumors With Only Liver Metastases
Beijing Hospital
Phase 2 Unknown
NCT04175899 2021-03-08
POCCP1
Ministry of Health, Malaysia
Phase NA Unknown
NCT04773808 2021-02-26
Molecular Characterization of Genetic Alterations in Pediatric Solid Tumors
National Council of Scientific and Technical Research, Argentina
Unknown
NCT04268108 2020-06-11
L-TIL in Patients With Malignancy Resistance to Anti-PD-1 Therapy
Henan Cancer Hospital
Unknown
NCT03975036 2019-06-05
Clinical Study on the Second-line and Above Treatment of Advanced Solid Tumor With Anlotinib Combined With Pd-1 Antibody
Henan Cancer Hospital
Phase 2/3 Unknown
NCT00886028 2009-04-22
Palliative Treatment With Liposomal Doxorubicin Plus Cisplatin for Patients With Malignant Pleural Mesothelioma
National Institute of Cancerología
Phase 2 Unknown